Promising Therapeutic Strategy for Alzheimer’s Disease Based on Specific Immune Cells
Researchers at Cedars-Sinai Medical Center recently published in the journal Brain a new promising immune therapeutic strategy for Alzheimer’s disease using mice models. The study is entitled “Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer’s disease”.